Clinical trial

Rituximab in Rheumatoid Arthritis Lung Disease

NCT00578565

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2007-05-01

PhasePHASE3

Study timeline

Study start (unknown)2007-05-01Date precision: month

Registry last updated2012-10-01

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Rheumatoid Arthritisunresolved

Interstitial Pneumoniaunresolved

Interventions

RituximabDRUG · verified · RxNorm: rituximab

Sponsors & collaborators

Eric Mattesonlead sponsor

Genentech, Inc.collaborator

National Center for Research Resources (NCRR)collaborator

Mapped research locations

BostonMassachusetts, United States1 RochesterMinnesota, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00578565 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.